Holen Sie sich die Stockscreener-App
0.869
0.21%
0.0018
Handel nachbörslich:
.85
-0.019
-2.19%
Zhengye Biotechnology Holding Ltd Aktie (ZYBT) Neueste Nachrichten
TradingKey - TradingKey
Zhengye (ZYBT) quarterly report delayed as CEO highlights strategic priorities; investors await key financial data.Beat Estimates - newser.com
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results - Tirto.id
China hog slump hits Zhengye as vaccine maker posts annual loss - Stock Titan
How risky is Zhengye (ZYBT) stock investment? (Institutional Selling) 2026-04-27Earnings Beat Stocks - newser.com
ZYBT Price Today: Zhengye Biotechnology Holding Limited Stock Price, Quote & Chart | MEXC - MEXC Exchange
Why Zhengye (ZYBT) Stock Could Rise (+3.79%) 2026-04-20Retail Picks - newser.com
Aiden Han Net Worth (2026) - GuruFocus
Wei Lian Net Worth (2026) - GuruFocus
Zhongyao Liu Net Worth (2026) - GuruFocus
Wenhua Sun Net Worth (2026) - GuruFocus
Trading Recap: Will Zhengye Biotechnology Holding Limited stock hit new highs in YEARQuarterly Trade Summary & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Zhengye Biotechnology implements dual-class share structure - Investing.com
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure - Weekly Voice
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure Effective April 7, 2026 - Quiver Quantitative
Zhengye's new share classes give some holders 20 votes each - Stock Titan
ZYBT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ZYBT Technical Analysis & Stock Price Forecast - Intellectia AI
Death Cross: How does Zhengye Biotechnology Holding Limited correlate with NasdaqInflation Watch & Stock Timing and Entry Methods - baoquankhu1.vn
Zhengye Biotechnology Shareholders Approve Governance and Share Structure Changes at March 24 AGM - TipRanks
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Why Faraday Future Intelligent Electric Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket - Benzinga
$Zhengye Biotechnology (ZYBT.US)$ still hodl some for moon - Moomoo
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Kyverna Therapeutics (NASDAQ:KYTX) and Zhengye Biotechnology (NASDAQ:ZYBT) Critical Contrast - Defense World
ZYBT Should I Buy - Intellectia AI
Zhengye Biotechnology Director Resigns, Nasdaq Independence Deficiency to Be Addressed at March AGM - TipRanks
Zhengye Biotechnology Holding Limited Announces Resignation of Wenbin Wang as Independent Director, Member of Committees, and Chairperson of the Compensation Committee, Effective February 18, 2026 - marketscreener.com
Will Zhengye Biotechnology Holding Limited benefit from geopolitical trendsChart Signals & Trade Opportunity Analysis Reports - mfd.ru
Zhengye Biotech chairman outlines 2025 achievements, 2026 strategy By Investing.com - Investing.com South Africa
Zhengye Biotechnology Holding Limited Issues 2026 Chairman’s Letter to Shareholders - GlobeNewswire
Pullback Watch: What is the Moat Score of Bold Eagle Acquisition Corp Equity RightEarnings Overview Report & Real-Time Buy Signal Alerts - baoquankhu1.vn
Aug Closing: Does Zhengye Biotechnology Holding Limited have a sustainable dividendJobs Report & Reliable Price Breakout Alerts - baoquankhu1.vn
Franklin Templeton Asset Management India Private Limited Ranks High in Smart Money TrackerProfit Target & Stepwise Trade Signal Guides - Улправда
Published on: 2026-01-08 23:11:28 - Улправда
Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Sees Large Decline in Short Interest - Defense World
Will Zhengye Biotechnology Holding Limited stock remain a Wall Street favoriteTrade Analysis Summary & Daily Profit Maximizing Trade Tips - Улправда
Why analysts upgrade Zhengye Biotechnology Holding Limited stockJuly 2025 Patterns & Low Drawdown Trading Strategies - Улправда
Zhengye Biotechnology (NASDAQ:ZYBT) Trading Up 2.8% – What’s Next? - Defense World
Can Zhengye Biotechnology Holding Limited stock beat market expectations this quarterTrade Exit Report & Reliable Breakout Forecasts - Улправда
Published on: 2025-12-19 15:28:57 - DonanımHaber
Zhengye Biotechnology (NASDAQ:ZYBT) Trading Up 2.8%What's Next? - MarketBeat
Can Zhengye Biotechnology Holding Limited stock hit record highs again2025 Trading Recap & Verified Swing Trading Watchlist - Улправда
Zhengye Biotechnology Holding Limited Reports Earnings Results for the Half Year Ended June 30, 2025 - marketscreener.com
Zhengye Biotechnology (ZYBT) Stock Analysis Report | Financials & Insights - Benzinga
Zhengye Biotechnology Holding Limited (ZYBT) stock price, news, quote and history - Yahoo Finance UK
Zhengye Biotechnology Holding Limited (ZYBT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Buyback Watch: Why analysts upgrade Zhengye Biotechnology Holding Limited stockJuly 2025 Chart Watch & Accurate Intraday Trade Tips - moha.gov.vn
Zhengye Biotechnology (NASDAQ:ZYBT) Stock Price Down 8.5%Here's Why - MarketBeat
Zhengye Biotechnology (NASDAQ:ZYBT) Stock Price Down 8.5% – Here’s Why - Defense World
Zhengye Biotechnology Holding Limited (ZYBT) Latest Press Releases & Corporate News - Yahoo! Finance Canada
Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) 26% Share Price Surge Not Quite Adding Up - simplywall.st
Why Actelis Networks Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket - Benzinga
Risks Still Elevated At These Prices As Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Shares Dive 79% - 富途牛牛
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.38% - Investing.com
Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday - Benzinga
Zhengye Biotechnology Holding L (ZYBT): A Closer Look at Its Market Position and Growth Challenges - DirectorsTalk Interviews
1.92%
4.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):